GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pa Shun International Holdings Ltd (HKSE:00574) » Definitions » 3-Year EPS without NRI Growth Rate

Pa Shun International Holdings (HKSE:00574) 3-Year EPS without NRI Growth Rate : 22.70% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pa Shun International Holdings 3-Year EPS without NRI Growth Rate?

Pa Shun International Holdings's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 22.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Pa Shun International Holdings was 24.20% per year. The lowest was -45.70% per year. And the median was -2.05% per year.


Competitive Comparison of Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate

For the Pharmaceutical Retailers subindustry, Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate falls into.



Pa Shun International Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Pa Shun International Holdings  (HKSE:00574) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Pa Shun International Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Pa Shun International Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pa Shun International Holdings (HKSE:00574) Business Description

Traded in Other Exchanges
N/A
Address
229 Wufuqiao East Road, No. 608-616, Building 28, Longfor North Paradise Walk 2, Jinniu District, Sichuan Province, Chengdu, CHN
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.
Executives
Zhongtai International Asset Management (singapore) Pte. Ltd. 2102 Investment manager
Arab Osman Mohammed 2104 Agent
Lai Wing Lun 2104 Agent
Win Win Stable No.3 Fund Sp 2106 Person having a security interest in shares
Zhongtai Innovation Capital Management Limited 2102 Investment manager
Chen Yenfei 2101 Beneficial owner
Praise Treasure Limited 2101 Beneficial owner

Pa Shun International Holdings (HKSE:00574) Headlines

No Headlines